The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,588.00
Bid: 13,216.00
Ask: 11,960.00
Change: -2.00 (-0.02%)
Spread: -1,256.00 (-9.504%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-COVID booster advice should come imminently, says UK minister

Sun, 28th Nov 2021 09:34

* UK wants to broaden booster campaign

* New measures are temporary

* Scotland also to introduce travel measures
(Adds Moderna's chief medical officer)

By Elizabeth Piper

LONDON, Nov 28 (Reuters) - Britain's health minister Sajid
Javid said on Sunday he expected to receive advice imminently on
whether the government can broaden a booster shot programme to
try to weaken the impact of the newly identified Omicron
coronavirus variant.

The government announced new measures on Saturday to try to
slow the spread of the variant, toughening rules for people
arriving into Britain and ordering the use of face masks in
retail settings and on transport in England.

But ministers also want to ramp up the offer of booster
jabs, saying even if vaccines prove to be less effective against
Omicron, they should offer better protection against it and
reduce the number of hospitalisations and deaths.

"The other thing that still remains hugely important, but I
think it's fair to say now more important than it was before, is
our vaccination programme," Javid told Sky News.

"That is why I have also asked our expert advisers on
vaccines called JCVI (the Joint Committee on Vaccination and
Immunisation) to give me very quick advice on broadening,
boosting our booster programme, and I expect to get that advice
imminently."

Earlier this month, Britain expanded eligibility for booster
jabs to people in their 40s and also said children aged 16 and
17 would be able to receive a second dose following guidance
from the JCVI.

Scotland, where the government sets its own rules for
health, already requires people to wear face coverings and work
from home if possible, but its first minister, Nicola Sturgeon,
told the BBC's Andrew Marr show she would also bring in new
rules for arrivals.

"I think we need to be open minded to doing anything
required to keep the population safe right now," she told the
BBC's Andrew Marr show.

The discovery of Omicron, dubbed a "variant of concern" last
week by the World Health Organization, has sparked worries
around the world https://www.reuters.com/world/new-coronavirus-variant-omicron-keeps-spreading-australia-detects-cases-2021-11-28
that it could resist vaccinations and prolong the nearly
two-year COVID-19 pandemic.

Britain has confirmed two cases of the new variant, and
Javid said the new measures were needed to buy time for experts
to try to understand more about Omicron, which may, or may not,
make vaccines less effective.

Paul Burton, chief medical officer at Moderna, said
if a new vaccine was needed to tackle the variant, "I think
that's going to be early 2022 before that’s really going to be
available in large quantities".

Javid repeated that it was not as yet clear whether vaccines
were less effective against the variant.

"The point is the vaccines are still going to give you more
protection than otherwise," he said. "That is why the booster
programme is so important."
(Reporting by Elizabeth Piper, Editing by Louise Heavens, Mark
Heinrich and Raissa Kasolowsky)

More News
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.